Clinical Trial Update: A Prospective Study on the Therapeutic Outcomes of Mebo and Tantum Verde in Patients With Oral Mucositis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the therapeutic outcomes of Mebo and Tantum Verde for oral mucositis due to radiation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis

Drugs mentioned

• MEBO (Moist Exposed Burn Ointment)
• Tantum Verde (benzydamine)

Snippet

Sponsor: Cairo University | Conditions: Oral Mucositis (Ulcerative) Due to Radiation | Phase 3 | Status: COMPLETED